ARTICLE | Product Development
Pfizer joins front of pack in COVID-19 vaccine race
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 29, 2020 1:17 AM UTC
A COVID-19 vaccine from BioNTech and Pfizer could be available for emergency use by October -- several months ahead of a J&J vaccine and just off the pace of vaccines from Oxford’s Jenner Institute and an undisclosed Chinese entity.
Pfizer Inc. (NYSE:PFE) said a U.S. trial of BNT162 is expected to start imminently; patients have already been dosed in a Phase I/II trial of the mRNA vaccine in Germany. ...